The Respiratory Collector industry trends over the past 18 months have been shaped by innovation and strategic collaboration. Key partnerships, such as the 2023 alliance between Aeris Health and LabCorp, have streamlined diagnostic workflows by integrating advanced sampling technologies with lab analytics. Meanwhile, mergers & acquisitions have accelerated, with ResMed’s acquisition of BreathTech Solutions in early 2024 expanding its portfolio of non-invasive respiratory monitoring tools. On the innovation front, companies like Viatom and Philips have launched IoT-enabled Respiratory Collectors with AI-driven data analysis, enhancing precision in chronic disease management. Regulatory shifts, including updated FDA guidelines for at-home respiratory device validation in late 2023, have spurred growth in decentralized care models. Enterprises are prioritizing portable, patient-centric designs to meet rising demand for remote monitoring, while startups like SpiroX raised $25M in Series B funding in 2024 to scale production of wearable collectors. These developments underscore a market shift toward digitization, accessibility, and AI integration, positioning the sector for robust growth in the coming years.
